Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00938964 · ClinicalTrials.gov registry record · NA
Lidocaine For Neuroprotection During Cardiac Surgery
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 550
- Enrollment target
NCT00938964 is a NA study that has completed, run by Duke University. The registered enrollment target is 550 participants.
The verdict
NCT00938964, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 550 participants
- Enrollment target
Study Summary
The purpose of this study is to see if a drug called lidocaine prevents cognitive injury (a decline in mental abilities) after heart surgery. Lidocaine is currently FDA approved and is commonly used for treating some heart rhythm disorders and for regional anesthesia (blocking nerves). The investigators are enrolling subjects in this research project to see if lidocaine will reduce the high incidence of cognitive injury seen after heart surgery. As part of this study, the investigators will also evaluate the relationship between cognitive injury and genetic makeup and the chemical changes in the subjects blood during and after surgery.
Interventions
- DRUG Placebo
- DRUG Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2009-07 |
| Est. Completion | 2017-05-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00938964
The ClinicalTrials.gov registry entry for NCT00938964 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00938964 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00938964 about?
NCT00938964 is a clinical study titled "Lidocaine For Neuroprotection During Cardiac Surgery". The purpose of this study is to see if a drug called lidocaine prevents cognitive injury (a decline in mental abilities) after heart surgery. Lidocaine is currently FDA approved and is commonly used for treating some heart rhythm disorders and for regional anesthesia (blocking nerves). The investiga...
What is the current status of trial NCT00938964?
This trial is currently completed. It is a NA study. The enrollment target is 550 participants. The study started on 2009-07. Estimated completion is 2017-05-23.
What interventions are being tested in trial NCT00938964?
The interventions under investigation include: Placebo (DRUG), Lidocaine (DRUG).
Who is sponsoring clinical trial NCT00938964?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.